Trial site
West China Second University Hospital
Chengdu, Sichuan 610101, ChinaNot linked to an institution yet
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Phase
- Phase 35 trials
- Phase 13 trials
- Phase 2/33 trials
- Phase 1/21 trial
- Status
- Active, not recruiting4 trials
- Not yet recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- West China Second University Hospital5 trials
- Children's Cancer Group, China2 trials
- Institute of Hematology & Blood Diseases Hospital, China2 trials
- Akeso1 trial
- Bayer1 trial
- and 3 more
Running trials
Not yet recruiting
Comparing the Efficacy of TU-LESS and vNOTES for Hysterectomy of Enlarged Uterus
NCT06663553· West China Second University Hospital· Source
Contact: Hongyu Jin, MD
Recruiting
Newly-diagnosed Pediatric T-cell ALL Protocol
NCT06855810· Phase 2/3· Institute of Hematology & Blood Diseases Hospital, China· Source
Contact: Ju Gao, MD
Recruiting
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
NCT06882057· Phase 2/3· Institute of Hematology & Blood Diseases Hospital, China· Source
Contact: Ju Gao, MD
Active, not recruiting
Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids
NCT06244251· West China Second University Hospital· Source
Recruiting
Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
NCT05681260· Phase 3· Children's Cancer Group, China· Source
Contact: Xia Guo, MD
Recruiting
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
NCT05533775· Phase 1/2· Hoffmann-La Roche· Source
Active, not recruiting
A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
NCT05235516· Phase 3· Akeso· Source
Active, not recruiting
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
NCT03519230· Phase 3· BeiGene· Source
Recruiting
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
NCT03463252· Phase 2/3· West China Second University Hospital· Source
Contact: Zheng Ying, professor
Active, not recruiting
LBL-2016 for Children or Adolescents in China
NCT02845882· Phase 3· Children's Cancer Group, China· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Completed
A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects
NCT07065058· Phase 1· Vincentage Pharma Co., Ltd· Source
Completed
A Study of HS-10518 in Healthy Adult Premenopausal Females in China
NCT07264192· Phase 1· West China Second University Hospital· Source
Completed
A Single-Center, Randomized, Open-Label, Two-Sequence, Two-Period, Crossover Study Comparing the Pharmacokinetics and Safety of Pyridostigmine Sustained-Release and Immediate-Release Tablets Following Single and Multiple Doses in Healthy Chinese Participants
NCT07154095· Phase 1· West China Second University Hospital· Source
Terminated
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
NCT03194646· Phase 3· Bayer· Source
Report an error